The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease.
about
CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rateHelicobacter pylori Infection in Gastroesophageal Reflux Disease in the Asian CountriesThe significance of cagA(+) Helicobacter pylori in reflux oesophagitisThe phenotype of gastric mucosa coexisting with Barrett's oesophagusIron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humansGastro-oesophageal reflux disease and Helicobacter pylori: an intricate relationHelicobacter pylori-reflections for the next millenniumEpidemiology of gastric cancer.Helicobacter pylori and gastric diseasesWhat's new in the pathology, pathophysiology and management of benign esophageal disorders?Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.H. pylori infection and reflux oesophagitis: a case-control studyClinical epidemiology and natural history of gastroesophageal reflux disease.Distinct variants of Helicobacter pylori cagA are associated with vacA subtypes.Role of corpus gastritis and cagA-positive Helicobacter pylori infection in reflux esophagitis.Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response.Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship?Treatment of Helicobacter pylori: an overview.Review article: is Helicobacter pylori status relevant in the management of GORD?IV. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation.Prevention of Gastric Cancer: When is Treatment of Helicobacter Pylori Warranted?Local and systemic immune and inflammatory responses to Helicobacter pylori strains.Review article: should we kill or should we save Helicobacter pylori?pathogenesis of Helicobacter pylori-induced gastric inflammation.Treatment of Helicobacter pylori.Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.Theodore E. Woodward Award: Global warming and the human stomach: microecology follows macroecology.Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysisThe prevalence of helicobacter pylori infection in patients with reflux esophagitis - our experienceEmpirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment.Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to ChinaHelicobacter pylori Has an Inverse Relationship With Severity of Reflux EsophagitisHelicobacter pylori Serology Inversely Correlated With the Risk and Severity of Reflux Esophagitis in Helicobacter pylori Endemic Area: A Matched Case-Control Study of 5,616 Health Check-Up Koreans.Trend in gastric cancer: 35 years of surgical experience in Japan.Patterns of gastritis in patients with gastro-oesophageal reflux diseaseHelicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretionInverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects
P2860
Q25257847-EC3B8777-420A-40F8-AAEF-554439019B4FQ28085263-40606373-9B69-4DF3-8202-9C16EA54713DQ28346251-C2ED8BD9-90E8-42A8-B1C6-954840E47C22Q28365932-CC714693-0A0D-4749-8D32-2183C3F748E9Q30530885-83BB67B3-0840-424A-8ABF-06CE148449BFQ33717334-254517B2-3EC3-4C29-B00B-BBF764D8B397Q33717367-0B8C1BEB-B745-48F1-AE15-15E14D3DA33BQ33788193-28940D4E-77A6-47C6-A1A3-30F5E8215342Q33790164-AE0A3956-DC2E-4C4F-87DA-F1FF2A3FD353Q33815326-42E8B1A3-F114-4240-8517-64B9DC36D66BQ33851569-800A3B65-FA9C-48AF-9EE7-F256498E2113Q33869224-E854CCD3-22BF-43D7-B23A-2D07F33E5450Q33898590-2047F989-684D-469B-ABB5-5100E6C1B083Q33961520-59006B85-E707-48B1-8C51-24377EF45554Q33964195-4FFAE786-F25C-454D-847F-EA62D7158DD8Q33971858-993D31D0-2194-43D9-8F06-65D408800A0DQ33994156-719C3473-37A6-4C66-AD92-D79A760738CEQ34028410-5246F87D-A87F-4AF1-830F-269E8F20B337Q34069820-B982FC21-ED7D-41B7-BC03-A9324DF20AE3Q34069835-EBB132AC-1A8F-4D4E-8AA2-77CC62DA7000Q34187131-9D848424-873F-4D67-A795-3A36648D75CCQ34197057-61B48788-1E4F-413A-BDE7-847322C113D0Q34231271-466259EC-0EB9-40F1-9BD5-DD8C1A125D86Q34327982-D79608AD-6C0D-49B7-B2BB-71719903549FQ34365936-E8EA4285-C4F4-4DCB-96EE-0BB9D3054A1DQ34512048-82EE966B-29B8-41A0-873C-0ED594682786Q34546045-4FD07BFB-E1FE-447E-9B69-A9EB679AD3DCQ34555425-C32A65B5-0BFC-4567-917D-CF33AF65496DQ34654959-8082C472-6227-4F29-8EB0-BD5910516D03Q34656407-2A1C2684-73C6-47BA-A19E-A82E3C96B9A7Q34745970-D665BD5F-71B3-4DC3-ACB8-D5DA33C09EBAQ35017527-72342482-4954-41AF-95CD-5A29265BECFCQ35099574-383B0667-1F1C-4C6A-BC81-6C69011B15CEQ35151103-401A815E-133E-46A3-B996-12C1B71F6C0AQ35161352-25719665-242A-4649-98E2-D4E30186FA0AQ35161377-9DA825DA-0711-4DDF-802A-30C72CB63EACQ35178076-D9F6FEC3-7203-4880-8657-44E347B1F2D7Q35357928-9AB6E263-882B-4AFF-B123-19BF878B1A19Q35364870-771C03A5-B7B9-42C2-8BE6-A52CDDD1C260Q35365038-25037858-83BB-4C32-A97E-166A70767C21
P2860
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
The seroprevalence of cagA-pos ...... stroesophageal reflux disease.
@en
The seroprevalence of cagA-pos ...... stroesophageal reflux disease.
@nl
type
label
The seroprevalence of cagA-pos ...... stroesophageal reflux disease.
@en
The seroprevalence of cagA-pos ...... stroesophageal reflux disease.
@nl
prefLabel
The seroprevalence of cagA-pos ...... stroesophageal reflux disease.
@en
The seroprevalence of cagA-pos ...... stroesophageal reflux disease.
@nl
P2093
P50
P921
P1433
P1476
The seroprevalence of cagA-pos ...... stroesophageal reflux disease.
@en
P2093
Goldblum JR
Perez-Perez GI
Richter JE
P356
10.1016/S0016-5085(98)70364-6
P407
P577
1998-07-01T00:00:00Z